CTSS and esophageal cancer: To study the ability of VGT-309 to label esophageal cancer at the cellular level, we first performed western blot analysis to confirm cathepsin expression in three murine and human esophageal cancer cell lines of varying histopathological subtypes (Figure 2(a)).